From the category archives:

IBS Points to Remember

FDA accepts Salix’s XIFAXAN550 sNDA for Priority Review

by lowes1 on August 10, 2010

Doctors hit out as Scots patients are denied new stomach cancer drug

by lowes1 on August 10, 2010

Researchers suggest manipulating microRNA-29a paves novel treatment for IBS

by lowes1 on August 9, 2010

Brave Maggie stars in UK campaign

by lowes1 on August 9, 2010

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Second Quarter Financial Results

by lowes1 on August 9, 2010

Salix Announces FDA Acceptance for Filing and Priority Review Designation For XIFAXAN550 sNDA For the Treatment of Non …

by lowes1 on August 9, 2010

Why antidepressants are simply a confidence trick: A leading psychologist claims taking sugar pills would work just as …

by lowes1 on August 9, 2010

Shire Proposes to Expand Specialist Gastrointestinal Portfolio

by lowes1 on August 9, 2010

New Research Finds Food Intolerance Key to Understanding Chronic Inflammation Disease

by lowes1 on August 9, 2010

Lexicon Pharma reacquires all rights to Symphony Icon programmes

by lowes1 on August 9, 2010

← Previous Entries